Abstract
INTRODUCTION
Cardiac surgery is a life-saving procedure in patients diagnosed with infective endocarditis (IE); nevertheless, the decision on whether to indicate surgery remains a challenge because of the high mortality rate [1, 2] . The current estimated incidence of IE is 3-10 episodes per 100 000 person-years, with an in-hospital mortality rate ranging between 9.6% and 27% [3, 4] . The perioperative mortality rate in IE patients varies considerably and depends on several factors, such as patient clinical characteristics, preoperative status, intraoperative difficulties and geographical variations [2] . The main indications to proceed with surgery in a patient with active IE are detailed in the consensus guidelines [3, 4] . However, it is also essential to consider each individual's surgical risk, which is estimated using risk scores. The decision to perform surgery is taken after carefully considering the balance between procedural risk and its estimated benefit. Therefore, surgical risk estimation is crucial to the surgical decision-making process.
The high risks associated with IE surgery and the uncertainty surrounding risk scores can cause problems in surgery indications, despite advances in diagnostic and therapeutic tools [5] . The utility of classical risk scores, used in routine clinical practice, has been widely debated in this scenario. The Society of Thoracic Surgeons (STS) score and the European System for Cardiac Operative Risk Evaluation (EuroSCORE) are the most employed scores; however, neither is specific for IE [6, 7] . The assessment of †Presented at the 31st Annual Meeting of the European Association for CardioThoracic Surgery, Vienna, Austria, 7-10 October 2017.
classical scores in IE has been widely evaluated previously, and a suboptimal prognostic ability has been confirmed [8] [9] [10] .
In recent years, new IE-specific risk scores have been developed. They incorporate some IE-specific factors (such as microbiological cultures, abscess formation and sepsis) that are known to be independent mortality factors [11] . IE-specific scores have demonstrated a more accurate mortality prediction than classical risk scores. The most widely employed IE-specific scores are (i) the STS-IE-specific score, developed by Gaca et al. [12] using the STS database; (ii) the De Feo-Cotrufo score, developed by De Feo et al. [13] for native IE, which is the recommended score in the current endocarditis guidelines [3, 13] ; (iii) the PALSUSE score, developed by Martínez-Sellé s et al. [14] and (iv) the Costa score, developed after a Brazilian study by Costa et al. [15] .
We assessed the prognostic utility of these 4 IE-specific risk scores to evaluate their reliability in mortality risk prediction for adequate surgical decision making in IE patients.
MATERIALS AND METHODS
A retrospective, observational and unicentric study was conducted. It included all patients who underwent cardiac surgery for active IE between 2002 and 2016. A total of 180 patients were included during the study period. IE affecting native and prosthetic valves were included; however, IE related to cardiac implantable electronic devices were excluded.
The primary objective was to evaluate the reliability of the different scores in predicting in-hospital mortality (including mortality during the first 30 days after the procedure if the patient was discharged alive). The logistic EuroSCORE I [7] , EuroSCORE II [6] , STS score, STS-IE score [12] , De Feo-Cotrufo score [13] , PALSUSE score [14] and Costa score [15] were calculated in all patients blinded to outcomes.
Definitions
• Heart failure was diagnosed on the basis of criteria guidelines [4] .
• Renal insufficiency was defined as the presence of a serum creatinine concentration >2 mg/dl.
• Paravalvular abscess was considered as an infection and necrosis with the formation of a purulent cavity with the capacity to invade structures [16] .
• Septic shock was defined as an acute circulatory failure due to sepsis, with persistent systolic pressure <90 mmHg, despite adequate volume resuscitation [17] .
• Cardiogenic shock was considered as acute circulatory failure due to myocardial dysfunction, with systolic pressure <90 mmHg, tissue hypoperfusion and low cardiac index [18] .
• Thrombocytopenia was defined as a platelet count of <150 000 platelets/ml.
• Vegetations were diagnosed and measured by transthoracic echocardiography.
• Atrioventricular block was considered as a conduction disorder whose presence was not known before the IE episode.
• Embolism was defined as the presence of embolic phenomena diagnosed by clinical data and complementary tests. Discrimination (capacity to predict mortality) was assessed by calculating the area under the receiver operating characteristic curve (AUC). Calibration (the agreement between predicted and observed probabilities, thereby dividing the sample into deciles of risk) was evaluated using the Hosmer-Lemeshow goodnessof-fit test.
Statistical analysis

Ethical considerations
The Ethical Review Board of the Hospital approved the implementation of this study (Ethical Review Board number 313/2016, approved on 28 November 2016). The requirement for informed written consent was waived. The identification of patients was encoded, complying with the requirements of the Organic Law on Data Protection 15/1999.
RESULTS
A total of 180 patients underwent surgery for active IE during the study period. The sample characteristics were stratified into 2 groups depending on survival ( Table 1 ). The mean age of the entire cohort was 63.20 years (standard deviation 1.0 years), and 121 (67.20%) patients were men. The affected valve was prosthetic in 37.22% and native in the remaining 62.78%. As expected, patients who died were significantly more sick; there was a higher percentage of patients in NYHA functional class worse than III, cardiogenic shock, septic shock and renal failure.
With reference to valve distribution, we found that IE affected approximately one-third each of aortic (36.84%), mitral (36.84%) and mitroaortic valves (26.32%).
Median time from diagnosis to surgery was 15.91 days (IQR 3-21 days), and 17.20% of patients underwent surgery within the first 48 h after diagnosis. The observed mortality was 26.82% [95% confidence interval (CI) 20.26-33.20%], including patients who died during the first 30 postoperative days, if discharged alive.
Predicted mortality risk
On the one hand, regarding classical risk scores assessment, the mean predicted mortality calculated by the EuroSCORE I was 33.76% (95% CI 29.68-37.84); by the EuroSCORE II was 14.12% (95% CI 11.72-16.52) and by the STS score was 10.71% (95% CI 8. 25-13.16) . It is important to note that it is not possible to calculate the STS score in IE patients with multiple valve involvement, because the STS score was developed for a single-valve pathology. Multiple-valve IE represented 26.32% of our sample (45/180 patients) in which the STS score could not be calculated. Moreover, mortality was significantly higher in multiple-valve IE compared with single-valve IE (odds ratio 3.97, 95% CI 1.93-8.19; P < 0.001). Consequently, the estimated mortality of the STS score was strikingly lower than the predicted mortality of the EuroSCORE.
On the other hand, IE-specific risk scores do not assess an estimated mortality (expressed as a percentage of the estimated mortality). Conversely, specific scores perform an additive calculation, providing a score number which classified the risk profile of the patient into low, intermediate or high risk.
The relationship between the median number of points and mortality, according to previously published data, is (i) 19 points (IQR [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] in the De Feo-Cotrufo score that corresponds to a mortality risk of 27.3% [13] ; (ii) 2 points (IQR 1-3) in the PALSUSE score that correlates to 15% of estimated mortality [14] ; (iii) 25 points (IQR 17-40) in the STS-IE score that corresponds to high risk, as the high risk cut-point previously employed was 22 points [12, 19] and (iv) 25 points (IQR 17-40) in the Costa score [15] that correlates with a 78.9% mortality risk.
Therefore, all 4 specific scores classified our sample as a high predicted mortality risk [10] .
Discrimination
Discrimination was evaluated using the AUC in each score. In classical risk scores, AUC was 0.74 (95% CI 0.66-0.82) for EuroSCORE I, 0.74 (95% CI 0.66-0.82) for EuroSCORE II and 0.73 for the STS score (95% CI 0.63-0.84).
In the same manner, in the specific scores, AUC was 0.76 (95% CI 0.68-0.82) for the STS-IE score, 0.68 (95% CI 0.58-0.76) for the De Feo-Cotrufo score, 0.73 (95% CI 0.66-0.79) for the PALSUSE score and 0.65 (95% CI 0.57-0.72) for the Costa score.
As a sensitivity analysis, as the De Feo-Cotrufo score has only been validated in native IE, the scores were estimated in native valve involvement (Fig. 1) in addition to the assessment of the entire population (Fig. 2) . In both cases, the STS-IE score showed the highest discrimination. Moreover, discrimination of the STS-IE score was statistically significantly higher when compared with the De Feo-Cotrofu score (P = 0.055) and Costa score (P = 0.024). However, there were no differences when comparing the STS-IE and PALSUSE scores (P = 0.58).
Calibration
Calibration was assessed using the Hosmer-Lemeshow test (HLt). Calibration was adequate in the STS score (HLt P = 0.29) and in EuroSCORE I (P = 0.26). Meanwhile, EuroSCORE II showed an inaccurate calibration (HLt P = 0.018).
The calibration was accurate in all 4 specific scores: HLt P = 0.28 for the STS-IE score; HLt P = 0.40 for the De Feo-Cotrufo score; HLt P = 0.46 for the PALSUSE score and HLt P = 0.37 in the Costa score.
DISCUSSION
The accuracy of preoperative risk scores used in cardiac surgery varies widely when the clinical setting is active IE. Classical score assessment had been evaluated previously, and a suboptimal prognostic ability was confirmed [8-10, 12, 20] . The obsolete EuroSCORE I overestimated mortality in our sample, despite having good calibration, while the EuroSCORE II tended to underestimate. The EuroSCORE II had adequate discrimination but suboptimal calibration (HL test P = 0.018), which could be related to the lack of specific IE factors (such as abscess and sepsis) [1, 2, 5] . The STS score showed optimal discrimination and calibration; however, it could not be universally employed because it excluded the multiple-valve IE patients. Multiple-valve IE patients represented one-third of our sample, and they had a higher surgical risk than patients with single-valve IE. Therefore, these 3 classical scores did not have optimal estimation in our sample.
New risk scores were specifically developed by the incorporation of IE-specific factors, and they could improve the decisionmaking process. As we have mentioned previously, Gaca et al. [12] developed a score after carrying out the largest surgical study based on the STS database and the STS-IE score. It included 13 variables that were independent mortality factors ( Table 2 ). The STS-IE score was validated in a large, prospective study performed by Chu et al. [19] who found that the STS-IE score could predict 6-month mortality. Accordingly, the STS-IE score had the best discrimination in our sample (AUC > 0.75) despite not including causal micro organism [19, 21] or the presence of intracardiac abscesses [22, 23] as independent mortality factors.
The PALSUSE score, developed by Martínez-Sellé s et al. [14] , showed good discrimination and calibration in our sample. It was developed from a multicentric cohort including 7 variables (Table 2) . It is important to mention that no validation was performed, and it included some variables that are also included in the EuroSCORE. Nevertheless, the PALSUSE score is an easy calculable score that could help in the identification of high-risk patients.
Although the score created by De Feo et al. [13] for native IE is the only one recommended in the new guidelines [3] , it had slightly lower discrimination in our sample (AUC = 0.68) when compared with the STS-IE score. The De Feo-Cotrufo score is also an easily applicable score that had showed non-inferiority when compared with the STS-IE score in the published literature [10, 12] . Its main drawback is the exclusion of prosthetic valve IE, which has been associated with higher mortality when compared with native valve IE [24, 25] . In addition, the score included the right-sided IE and recovered patients. Consequently, the mortality estimation was strikingly lower (9.1%) than other published articles, and it makes the score less applicable to the general population.
The score published by Costa et al. [15] was created after a Brazilian single-centre study, including not only the patients who underwent surgery but also the patients who were treated with antibiotics. The authors did not find any relationship between sex and mortality or the infectious agent and mortality. Therefore, casual micro organisms and sex were not independent variables in this score. In addition, valve dysfunction did not affect mortality, and emergency surgery was not considered. In the Costa score, 4 risk groups were identified based on 7 variables ( Table  2 ). The risk group allowed the estimation of mortality risk using probability calculations. In our sample, the Costa score had the worst discrimination (<0.65) of all the specific scores analysed. IE-specific risk scores showed improved calibration because they included IE-specific factors that can impact mortality and which are not addressed by classical risk scores. Therefore, it is possible that they could predict mortality with higher accuracy than classic risk scores. For example, any young man with prosthetic IE would always have the same EuroSCORE II, but his risk would be different if IE was caused by Staphylococcus or if he had an abscess or persistent fever despite antibiotic treatment. Consequently, risk would be more accurately estimated by specific scores, and the calibration of the scores would improve in a big sample. Previously published studies have compared classical risk scores with specific scores [10, 14] , but to our knowledge, this study is the first in which 7 scores were assessed.
Limitations
Our study had several limitations. The primary limitation was the small sample size. Only 180 patients were included, and we did not have reliable outcome data for 2 of them, whom we excluded. In addition, it was a single-centre retrospective observational study, and a potential bias inherent to observational studies was present. The study incorporated patients from 2002 to 2016. During this time, some of the scores made have suffered a calibration loss because of changes in patient characteristics and cardiac surgery approaches. Furthermore, we analysed the in-hospital mortality rate as the main outcome, and we did not assess long-term prognosis. The study may also have a potentially referral bias, because it was developed in a tertiary centre. We only included patients who underwent surgery for active IE, and as a consequence, our results are not applicable to patients with healed endocarditis or patients treated medically. We excluded IE due to implanted device infections, unless it affected heart valves. Regarding missing data, we lost information regarding 2 patients in our sample.
In summary, the 4 specific scores analysed in our study showed better prognostic accuracy than classical risk scores. It is important to note the differences between the 4 scores in terms of calibration, discrimination, variables included and risk assessment. We found that critical preoperative status, emergency surgery and cardiac shock are almost always universal predictors of poor prognosis after cardiac surgery. As a consequence, they are independent variables in all of the analysed scores but weighted differently in each score (Table 2 ). For example, in the PALSUSE score, an emergency is an independent variable; however, critical state is included in the evaluation of the EuroSCORE. Moreover, in the STS-IE and in the De Feo-Cotrufo scores, the preoperative haemodynamic condition was the greatest predictor of mortality. The presence of abscesses and large intracardiac destruction are not included in the STS-IE score. Prognostic implications of prosthetic valve IE have been reported elsewhere [24, 25] , but it is not applicable to the De Feo-Cotrufo score that includes only native valve affection.
CONCLUSION
In conclusion, the STS-IE score and PALSUSE score were the best predictors of surgical risk in our sample. The De Feo-Cotrufo score for native IE had lower discrimination despite being recommended in the current guidelines. The Costa score showed a worse preoperative risk assessment in comparison with the other 3 scales. A multicentre validation of specific scores should be performed to evaluate whether they could improve IE mortality prediction.
